- Location
Edema
"-
SMC Has Accepted ILUVIEN for Use Within The NHS
Feb 25, 2014pSivida Corp. (NASDAQ: PSDV) (ASX: PVA), a leader in the development of sustained release, drug delivery products for treating eye diseases, today announced that the Scottish Medicines Consortium (SMC) has accepted ILUVIEN® for use ...
-
Women with Gestational Hypertension or Preeclampsia Between 34 and 37 Weeks of Pregnancy
Feb 14, 2014In a study to be presented on Feb. 6 at 8:15 a.m. CST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting -, in New Orleans, researchers will report findings that recommend expectant monitoring instead of ...
Tags: Gestational Hypertension
-
UV, Blue and Far-Red Light Can Prevent The Development of Edema on Some Plants
Jan 10, 2014UV, blue and far-red light can prevent the development of edema on some plants in the tomato family. Edema is a physiological disorder characterized by watery blisters or tumors that often form along leaf veins. It can develop on plants, ...
Tags: Edema, Light Quality, Development of Edema
-
Adults Losing Their Vision to Diabetes Were Told That Diabetes Could Damage Their Eyesight
Dec 25, 2013Less than half of adults who are losing their vision to diabetes have been told by a doctor that diabetes could damage their eyesight, a new study found. Vision loss is a common complication of diabetes, and is caused by damage that the ...
-
Unilife Has Announced The Signing of an Agreement
Dec 18, 2013Unilife, a medical device and technology company, has announced the signing of an agreement with a global pharmaceutical company seeking to use the Unilife Ocu-ject ocular drug delivery system to deliver a target injectable therapy into the ...
Tags: Unilife, medical device
-
Bayer HealthCare Has Submitted VEGF Trap-Eye for Regulatory Approval in Japan
Dec 5, 2013Bayer HealthCare has submitted VEGF Trap-Eye (aflibercept solution for injection) for regulatory approval in Japan to treat patients with myopic choroidal neovascularization (myopic CNV), one of the most common causes of eye disease. In ...
-
Bruin Biometrics Has Reported Results Clinical Trials Conducted with Its SEM Scanner
Nov 29, 2013Bruin Biometrics has reported results from the two Institutional Review Board-approved clinical trials conducted with its SEM Scanner to detect pressure ulcers. SEM Scanner is a class IIA medical device developed by Bruin Biometrics in ...
Tags: Biometrics, Health, Medicine
-
Bayer and Regeneron Pharmaceuticals Are Collaborating on The Global Development of Eylea
Nov 26, 2013Japan's Ministry of Health, Labour and Welfare (MHLW) has approved Bayer HealthCare's Eylea (aflibercept, solution for intravitreal injection) for the treatment of macular edema secondary to central retinal vein occlusion (CRVO). In ...
-
Lemon's Health Benefits Are Due to The High Concentration of Vitamins B and C
Nov 19, 2013When life gives you lemons, make lemonade and dozens of other foods and home remedies from this versatile fruit. Lemon's health benefits are due to the high concentration of vitamins B and C, antioxidants, protein, flavonoids, phosphorus, ...
-
Bruin Biometrics Has Obtained CE Mark Approval to Market Its Sem Scanner
Nov 15, 2013US-based Bruin Biometrics has obtained CE Mark approval in the EU to market its SEM scanner, a class IIA medical device intended to detect pressure ulcers before they show up on skin's surface. The hand-held device is intended to detect ...
Tags: SEM Scanner, hand-held device
-
A Single U.S. Baby, $105,000 for Twins and More Then $400,000 for Triplets or More
Nov 15, 2013It costs $21,000 per delivery for a single U.S. baby, $105,000 for twins and more then $400,000 for triplets or more, researchers say. Lead investigator Dongmu Zhang of Global Health Outcomes, Merck & Co. and colleagues analyzed and ...
-
Allegro Ophthalmics Has Received Approval From FDA for IND Application
Oct 11, 2013Allegro Ophthalmics has received approval from the US Food and Drug Administration (FDA) for its Investigational New Drug (IND) application to commence two Phase II clinical studies of integrin peptide therapy ALG-1001. The new trials, ...
Tags: Eye Disease Patients
-
European Commission Has Approved Regeneron Pharmaceuticals's Eylea Injection
Sep 2, 2013The European Commission has approved Regeneron Pharmaceuticals's Eylea (aflibercept) injection for the treatment of visual impairment caused by macular edema secondary to central retinal vein occlusion (CRVO). Eylea is a recombinant ...
Tags: fusion protein, Eylea
-
Know More About Risks Associated with Caustic Soda
Jun 24, 2013Risks are associated with almost all kinds of chemicals whether they are using for industrial purpose or for household. Some chemicals are hazardous and require extra attention and care while dealing and Caustic soda or Sodium Hydroxide is ...
Tags: Chemicals, Caustic Soda
-
a New Method for The Diagnosis of Retinal Microaneurysm Was Ethan Launched
Jun 13, 2013The Hebrew University of Jerusalem’s Yissum Research Development Company has developed a novel method to diagnose retinal micro-aneurysms that pose a high risk for leakage, a primary cause of diabetic retinopathy. The novel method ...
Tags: Yissum, Retinal Micro-Aneurysms
Related Products
-
Seamless Non-Binding Diabetic Socks, Single-Layer Cuff Anti-Bacterial for Edema Neuropathy
-
Compression Socks Funny Animal & Alien Socks Running Men Women Compression Socks for Medical, Edema, Diabetes, Varicose Veins
-
Wireless Rechargeable Portable Dvt Prevention Leg Circulation Wrap Air Compression Pump
-
Medical Care Compression Dvt Pump Intermittent Pneumatic Compression Device
-
Magnesium Sulfate External Treatment Powder Hot Compress Edema
-
Private Label Nursing Stocking Scrunch Calf Sleeves Moderate Edema Recovery Medical Compression Socks for Women
